"Two record setting sales days is what one update was about."
Barnhizer has once again showed how a typical stinky pink stock company rolls. He is simply cherry-picking the data he feeds to the uber-bulls to keep them from whining to him too much. In fact, I wouldn't be surprised if he released this tidbit exactly because he has been getting more and more panicky calls from the friends&family gang.
Of course serious investors wouldn't give him a pass on this, let alone get excited enough to now buy NNLX stock. As keembo observed, highlighting one-day sales data without sharing the type of quarterly or monthly numbers real public companies regularly and predictably release for context is a joke, making it, IMO, pretty clear what Barnhizer's motivation for doing this was.
"Zagenda/Nmbr1stockpicker on I-Hangout - "Just more of what one would expect from a bunch of losers -- laying blame for their failures at others' feet."
I guess when somebody buys stock at .48 or .49/share and it now trades at .03 ( on a day it trades at all), that should qualify as a failure on the part of the stockpicker or purchaser. Ya follow?"
Here is what nmbr1 was expecting back in Feb 2013:
"So, focus your attention on BNP and BNF and their growth -- which we have no clue about at this time, which is why I think your model doesn't work.
All you have are qualified assumptions about investors' assumptions on market penetration of BNP and BNF. What do we know?
by the end of 2013, my assumptions:
- EPA will have begun adopting BNP/BNF.
- Giles will have BNP and BNF as the standard product in all GBS testing.
- WHO will be close to endorsing BNP/BNF for TB testing worldwide.
- we'll here some news from governmental agencies that have adopted BNP/BNF.
in 2014: sales of all the assumptions listed above PLUS many others."
Nmbr1 either has a spotless mind and doesn't remember posting any of these reasonable expectations that never materialized or only meant others to take his "assumptions" seriously and get excited about the near term company prospects. Lather, rinse, repeat.
"Way before my time oatmeal brain"
Don't be so modest, mitsy. While this alias born-on date may be relatively recent, the person behind it posts as if (s)he has extensive, if selective, knowledge of this company's history, as well as the CEO's. Take for instance that rather bizarre nugget of trivia you posted on this board last year about the number of "NVA"s Barnhizer allegedly killed during the Vietnam War.
Back to what matters, though, I get that a true believer may need to "adjust" the company's historical record and claim no recollection of that which never materialized; minimizing cognitive dissonance and being highly susceptible to confirmation bias are to be expected. Whatever helps you get through the night, especially when a company keeps its shareholders in the dark as much as this one does.
"Weren't we supposed to hear something back from the EPA by mid 2015???? A little past that - aren't we?"
Par for the course in NanoLand. Here's what was stated a year ago ("Resources" webpage) that **will** happen to document the claims about Barnhizer's much-hyped flat packaging:
"A peer reviewed paper will be published either in 2014 or early 2015 detailing the actual studies with results and control data."
Has anyone seen this peer-reviewed paper? Or is this yet more classic Barnhizer OPUD? I couldn't find mention of it on the NNLX website and, well, this is just the type of news Barnhizer would put front and center.
But if the paper got rejected, what does that say about the flatpack claims? No worries, though, because just the thought of another science paper being published was likely enough to keep the true believers salivating with anticipation until the next anticipated/pending catalyst was announced. Lather, rinse, repeat.
"Dr. Manley is now a very successful malpractice lawyer in Baltimore and nanomoron apparently confused the distinct difference of suing for medical malpractice with being sued for it."
Interesting observation, Mitsy, and if true you may be on to something: Perhaps the reason Manley seemingly did not get the desired outcome from his stated commitment to doing what he could to get "necessary trials started and finished" is because he's now an ace malpractice lawyer.
Maybe that career change (aka going to the dark side?) you describe as being so successful also alienated him from some of his old medical colleagues. What do you think of that hypothesis? Hey, given the lack of real answers from the company, I think this is as good of a guess as any to explain why things didn't turn out as he hoped. This from the Nov. 2012 company PR announcing his SAB appointment:
"Through my career I have formed acquaintances with the Chiefs of Obstetrics at some of the top medical institutions in our country. I will make a concerted effort to get the necessary trials started and finished at places such as Harvard, Johns Hopkins and other institutions. I am hopeful that by the end of 2013 the standard for GBS screening will include our near-15 minute test at time of labor.”
"...I think Dr Jan? predicted it would be $2 and paying a dividend by Jan 2014, not 2015."
The message boards are littered with outrageous predictions for this stock. And speaking of pumper-doctors, here is a prediction from giles_manley, the poster alias I believe for a guy Barnhizer subsequently recruited to be on the company's SAB, that was posted in Feb 2012:
"This is one technology, finally, that I am very familiar with. If I had to estimate, this company will be bought out somewhere in the next 1-3 years between $8-10/share. There is nothing even close on the market, and soon every pregnant woman will be tested using there technology, worldwide."
And here are a couple more giles' gems also from other posts made in Feb 2012:
"btw...i spoke with Brett yesterday...all great news...and i am looking into buying another 500,000 shares of restricted stock...i am the kind of person that always figured i would work until i drop....i am counting on this company to change that from 80 hour weeks...to 20 hour week!"
"They could probably get $3-5/share now in a buyout or, if everything falls in place, be a company trading at ??????$50-100/share in a few years...
Just bought another 30,000 shares at .48 and .49!"
"I tried to bump it to .50.
Bought another 50,000 shares just before closing. Glad to say highest came in at .45!
I love this company...and foolish or not, as it is a technology I totally understand, and believe in, I am positioning myself for early retirement!....he says hopefully:)"
"That nasty word "projected" seems to be one of Bret's favorites. He does it every time."
"Projected" is not a nasty word for competent CEOs and management teams. Setting goals and tracking projections are important to businesses as they try to grow and are good benchmarks against which to assess managerial performance. Public companies also have an obligation, IMO, to share these with their owners (i.e., shareholders) and should be held accountable if they are not achieved.
To the extent that OPUD (over-project, under-deliver) and hype have been observed here over many years is a fair indicator of both Barnhizer's managerial competency and the commercial appeal of the products NNLX has developed/marketed or trumpeted as coming soon.
"The FINRA investigator stated that they have nothing to do with stock manipulation and it's the SEC's area. Why don't you contact them and report yourself as a pump and dumper? Perhaps they'll listen to your confession."
Admittedly I have little motivation to initiate any official action at this time but if you post the name of the FINRA investigator with whom you spoke and the case number assigned to your complaint, I'll contact that fine public servant, share what I know and then post what she has to say about the possibility of pump-and-dump activity associated with this stock.
You also highlight a time period, starting from last Oct when the company released its Ebola PR and the stock spiked but then deflated and dropped even lower, that may have some concurrent trading action that, if not illegal, would seem to be par for the course for "public" companies trading as stinky pink sheets.
For example, I'd ask your FINRA contact to investigate whether any PIPE shares were sold just as/after the stock was spiking and if any who bought those shares also sold any of their current holdings at about the same time they were buying the discounted PIPEs. If FINRA (or the SEC) was willing to investigate and get some transparency on who the players are; what they were posting on public boards; and whether this is part of a pattern with previous spikes and drops that would be worth my time. I don't know if such activity is illegal but it would likely at least be a cautionary eye-opener for some who don't think these things occur.
Again, post the name of the FINRA investigator and your complaint case number and I'll do my best to move this along for you.
No doubt the alias is just another cover for one of the established players here. I don't get the need to "cross-dress" and overplay the gender-speak but it wouldn't be the first time (right, Sean???).
"I've made lots on this and others lately. I've bought at the dips that you and your friends created and sold higher. Our investment club spotted what you boys were doing last year to manipulate the price."
Congrats to you and your group! You have to be savvy day-traders indeed to make money on the long side of this stock over the past several years, dumping shares on the small upticks that are part of the long-term precipitous drop in pps. Based on what you've shared, it's only the buy-and-hold true believers that have been big losers in this stock. Again, well done with your nimble trading!
" I reported you to FINRA but they said it's the business of the SEC."
They really told you that? This is how FINRA describes its investigative scope:
"The Fraud Surveillance Group analyzes trading across all equity markets, and detects and investigates fraudulent or manipulative activity, including issuer fraud, pump and dump stock schemes, market manipulation and account intrusions."
Isn't pump-and-dump or organized manipulation what you were asserting to be happening here? At any rate, did you follow-up w/SEC? You certainly seem convinced some long-running nefarious and illegal activity is happening with this stock. Well, at least you and your gang are profiting from it.
And FINRA didn't pass on your complaint to SEC? That seems to be the standard practice:
"The department coordinates with Enforcement and other FINRA Departments to aggressively pursue matters under FINRA's jurisdiction, and refers matters involving potential fraud and misconduct that are outside of FINRA's jurisdiction to the U.S. Securities and Exchange Commission (SEC) or other regulators or law enforcement agencies for further investigation. In 2014, OFDMI referred more than 700 such matters. The SEC has kindly acknowledged FINRA's assistance in certain of its Litigation Releases."
Keep up the interesting posting and best of luck eeking more profits trading this stock; Barnhizer should be proud!
"Did you look at the CEO's connections there. It's not Facebook and a gossip forum, the man has 900 connections and most of them appear very well positioned."
So the conversation has once again turned to Barnhizer's LinkedIn bona fides? Last year the bootlickers were drooling over the supposed LinkedIn connection between Barnhizer and some Gates Foundation people. Surely, they posted, this was a clear sign GF would soon be sending money to NNLX. Well, they got it half-right because GF continues to award millions to those companies it deems to have sufficiently validated and promising technologies. Yet, NNLX appears to still be on the outside looking in with hat in hand. Has it ever announced the award of any grant money from any source after all these years?
Yes, if LinkedIn connections and the length of self-promoting bio info a CEO puts on her company website were reliable indicators of a company's potential and value to investors, NNLX should have a market cap closer to AAPL instead of wallowing deeply in the stinky pink muck. Just what gives if Barnhizer is, as implied, so highly regarded? If he's such a well-connected businessman then logic seems to point to tech that remains flawed or commercially unappealing behind the gap between the big talk and poor performance.
On the plus side, Barnhizer does have a lot of old PR material, such as this June '07 quote from when he was trumpeting a manufacturing agreement for BNC parts, that can be dusted-off and re-used with only minor alterations to highlight its emerging tech du jour :
" Bret T. Barnhizer, Chairman, CEO and President of NanoLogix stated:
"All of what is occurring is very exciting and positive in scope. We look
forward to the results of our team effort and the establishment of a strong
revenue stream for the company from those efforts. We will work at keeping
the investing public informed of our progress and..."
...Just keep following the bouncing ball: BNC. BNP. BNF. N-Assay. Etc. Etc. Etc
" Anyone want to join me so I'm not bored with only my mail-order bride and the staff help? ;-)"
Take good care!"
If only that guy took his own advice and took better care of what he posted he wouldn't have had to scrub so much embarrassing stuff that spanned years and years.
So what kind of husband would publicly label his a wife a "mail-order bride" or use her as an example of an unsophisticated, newbie investor because she wanted him to sell when NNLX was trading around $1? And being one of Barnhizer's close buddies and dependable board mouthpieces certainly provided plenty of material that later looked to be perhaps too revealing to leave undeleted on this board.
Here's another golden-oldie: Remember in the early days when the uber-bulls were excitedly tallying their individual ownership stakes on this board? Barnhizer even got in on that under the posting alias "veteran12005" when it seemed he and PDE were neck-and-neck at the top of the list. Here's what he shared in one post:
"veteran12005 • Oct 10, 2008 9:07 PM
closing onto four million, Petro is behind me a bit, but I have been involved with the company longer so he has to play catch-up. I believe I first told him about the stock while we were in Budapest in 2005"
"How about that, these 2 doctors & researchers have day jobs too."
And don't forget they probably have lawns that need to be mowed on a regular basis. As Barnhizer apparently wrote in a recent email, clearly some people just don't appreciate the situation cash-strapped "start-ups" are in and how difficult it may be for such companies to get diagnostic tech commercial-ready... including, IMO, the person who wrote this:
"April 05, 2013:
NanoLogix plans to begin marketing this summer of their new N-Assay Multiwell Diagnostic test. The N-Assay is a machine-readable test that will be available in an assortment of size configurations for detection and identification of a variety of bacteria. Tests to date have provided consistent results in as little as 30 minutes with both high sensitivity and specificity. "
With scant reporting to indicate much recent sales interest in BNP and prominent product mention of BNF now scrubbed from the company website (and don't forget BNC!), N-Assay is indeed the shiny object for the true believers to fixate on. Any word on how PIPE sales are going these days?
"How about calling in and asking about this "US FDA for acceptance as a non-invasive diagnostic technology."?"
Don't rain on the dreamers' parade. Barnhizer has spoken: 2016 looks to be the new 2015, which was the new 2014, which was the new 2013, etc... Now he has them drooling over what will happen when further research is finally complete and another paper published. And don't bother to ask just who owns the N-Assay patent or how that revenue pie, if it ever comes to be, gets sliced.
Hey, back in 2013 Barnhizer announced how he had hired some pros to promote NNLX proprietary products:
In 2013, NanoLogix contracted with a team of independent marketing specialists to promote the Company’s products to key opinion leaders (KOLs) and executives in multiple health, industrial, pharmaceutical and food sectors. The marketing team is composed of current or former directors and managers of two national and international pharmaceutical corporations. This alliance continues the transition of the Company from a primary focus on research and development to one of production and marketing."
Last year, it was a group of marketing students from a nearby college he consulted to identify marketing opportunities overseas:
“We at NanoLogix were impressed with the results of the marketing study compiled by the student team from the export class at the Williamson College of Business Administration at YSU,” said Bret Barnhizer, chief executive of NanoLogix Inc.
Who knows, maybe he's lining-up the Hubbard High DECA club to help with the big N-Assay launch... And this time he means it:
"April 05, 2013:
NanoLogix plans to begin marketing this summer of their new N-Assay Multiwell Diagnostic test. The N-Assay is a machine-readable test that will be available in an assortment of size configurations for detection and identification of a variety of bacteria. Tests to date have provided consistent results in as little as 30 minutes with both high sensitivity and specificity."
"How do things go from a "very successful exhibit" , "interest was renewed", & "new interest was generated",
to now not exhibiting at ASM this year because reportedly it was not cost effective. What happened to the interest 4 years later from these entities?"
One doesn't have to go back even that far to find examples of the company blabbering on about how they wowed people at these exhibits. Here's what was stated about a year ago while the 2014 ASM was ongoing:
"NanoLogix is currently attending and exhibiting at the American Society for Microbiology Annual Meeting (ASM) in Boston, MA. Interest in the Company’s existing products and emerging technology at the ASM during the first two days of the exhibition has been very strong."
Interest very strong during just the first two days! How about actual sales of proprietary products other than newly manufactured PIPE shares? Funny how NNLX stopped posting quarterly financial results again after Q3 2014.
And here's a statement from what was posted on the company website when the Saudi deal was announced in Jan 2014. It contains a couple noteworthy claims that the friends&family should seek to fully understand as part of their penetrating due diligence:
"NanoLogix, Inc. is a biotechnology company headquartered in Hubbard, Ohio. The company manufacturers four major types of technologies: BNF, BNP, N-Assay, and Flatpack packaged petri plates. The company currently holds relationships with nine countries in four continents. The first year of sales for NanoLogix Inc. is projected to total $900,000 from this contract."
It's been over a year so how much revenue has come from the Saudi partner to date? How much revenue has been generated due to the "relationships" that span nine countries on four continents? What was the manufacturing activity for the "four major types of technologies" in 2014 and so far in 2015?
Oh, never mind, Barnhizer got a packaging patent in China so strap-in because it's liftoff time!
"The Company expects the patent to provide assistance in marketing for our Singaporean representatives and anticipates sub-licensing rights for use and manufacture to a group or groups in the region. "
What a joke. Getting a packaging patent in China for something the company only licenses itself is what was holding back sales of NNLX proprietary products or its agar dishes?!?! No wonder this "news" went out just to the true believers. Who else would believe a patent grant for Barnhizer's vacuum bags has been the crucial missing piece of the marketing puzzle before a torrent of sales orders comes in from Asia? There's no doubt about it: The family&friends gang are his best customers-- for PIPE shares that is and that's been the company's best-selling "product" for years!